Reward-based programs lead to higher rates of smoking cessation
the ONA take:
Reward-based lead to higher rates of sustained abstinence from smoking compared with deposit-based programs and group-oriented incentive programs are no more effective than individual-oriented programs, a new study published in The New England Journal of Medicine has shown.
For the study, researchers enrolled 2,538 CVS Caremark employees and their relatives and friends and randomly assigned them to one of four incentive programs or to usual care for smoking cessation.
Reward-based programs involved participants receiving about $800 for smoking cessation while the deposit-based programs entailed refundable deposits of $150 plus $650 in reward payments.
Results showed that rates of sustained abstinence from smoking through 6 months were higher in each of the incentive programs compared with usual care and the superiority of reward-based programs lasted through 12 months.
Researchers found that group-oriented and individual-oriented were associated with similar 6-month smoking cessation rates.
The study also showed that reward-based programs led to higher abstinence rates compared with deposit-based programs.
Reward-based lead to higher rates of sustained abstinence from smoking.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|